{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:22:53Z","timestamp":1792624973175,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T00:00:00Z","timestamp":1530144000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s10096-018-3300-0","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T17:05:11Z","timestamp":1530205511000},"page":"1687-1697","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Extremely and pandrug-resistant bacteria extra-deaths: myth or reality?"],"prefix":"10.1007","volume":"37","author":[{"given":"C\u00e9dric","family":"Abat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Edouard","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Th\u00e9r\u00e8se","family":"Jimeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Rolain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Raoult","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,28]]},"reference":[{"key":"3300_CR1","unstructured":"ECDC\/EMEA Joint Technical Report (2009) The bacterial challenge: time to react. 2009. \n                    http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf\n                    \n                  . Accessed 17 May 2018"},{"key":"3300_CR2","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/nrmicro2693","volume":"9","author":"K Bush","year":"2011","unstructured":"Bush K, Courvalin P, Dantas G, Davies J, Eisenstein B, Huovinen P et al (2011) Tackling antibiotic resistance. Nat Rev Microbiol 9:894\u2013896","journal-title":"Nat Rev Microbiol"},{"key":"3300_CR3","unstructured":"World Health Organization (2014) Antimicrobial resistance: global report on surveillance. \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/112642\/1\/9789241564748_eng.pdf\n                    \n                  . Accessed 17 May 2018"},{"key":"3300_CR4","unstructured":"Colomb-Cotinat M, Lacoste J, Coignard B, Vaux S (2015) Morbidit\u00e9 et mortalit\u00e9 des infections \u00e0 bact\u00e9ries multi-r\u00e9sistantes aux antibiotiques en France en 2012. \n                    http:\/\/invs.santepubliquefrance.fr\/content\/download\/116892\/409658\/version\/1\/file\/Rapport_DMI_RATB_Burden_BAT.pdf\n                    \n                  . Accessed 17 May 2018"},{"key":"3300_CR5","unstructured":"O\u2019Neill J (2014) Antimicrobial resistance: tackling a crisis for the health and wealth of nations. \n                    https:\/\/amr-review.org\/sites\/default\/files\/AMR\n                    \n                   Review Paper - Tackling a crisis for the health and wealth of nations_1.pdf. Accessed 17 May 2018"},{"key":"3300_CR6","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.3201\/eid2108.141419","volume":"21","author":"C Abat","year":"2015","unstructured":"Abat C, Chaudet H, Colson P, Rolain J-M, Raoult D (2015) Real-time microbiology laboratory surveillance system to detect abnormal events and emerging infections, Marseille, France. Emerg Infect Dis 21:1302\u20131310","journal-title":"Emerg Infect Dis"},{"key":"3300_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jhin.2004.01.003","volume":"56","author":"C Dobbin","year":"2004","unstructured":"Dobbin C, Maley M, Harkness J, Benn R, Malouf M, Glanville A et al (2004) The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre. J Hosp Infect 56:277\u2013282","journal-title":"J Hosp Infect"},{"key":"3300_CR8","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.healun.2007.05.018","volume":"26","author":"D Hadjiliadis","year":"2007","unstructured":"Hadjiliadis D, Steele MP, Chaparro C, Singer LG, Waddell TK, Hutcheon MA et al (2007) Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria. J Heart Lung Transplant 26:834\u2013838","journal-title":"J Heart Lung Transplant"},{"key":"3300_CR9","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ijantimicag.2008.05.016","volume":"32","author":"ME Falagas","year":"2008","unstructured":"Falagas ME, Rafailidis PI, Matthaiou DK, Virtzili S, Nikita D, Michalopoulos A (2008) Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients. Int J Antimicrob Agents 32:450\u2013454","journal-title":"Int J Antimicrob Agents"},{"key":"3300_CR10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1086\/600042","volume":"49","author":"A Elemam","year":"2009","unstructured":"Elemam A, Rahimian J, Mandell W (2009) Infection with panresistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literature. Clin Infect Dis 49:271\u2013274","journal-title":"Clin Infect Dis"},{"key":"3300_CR11","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.cmi.2016.03.012","volume":"22","author":"J-M Rolain","year":"2016","unstructured":"Rolain J-M, Abat C, Jimeno M-T, Fournier P-E, Raoult D (2016) Do we need new antibiotics? Clin Microbiol Infect 22:408\u2013415","journal-title":"Clin Microbiol Infect"},{"key":"3300_CR12","first-page":"7","volume":"9","author":"S Ram\u00edrez-Estrada","year":"2016","unstructured":"Ram\u00edrez-Estrada S, Borgatta B, Rello J (2016) Pseudomonas aeruginosa ventilator-associated pneumonia management. Infect Drug Resist 9:7\u201318","journal-title":"Infect Drug Resist"},{"key":"3300_CR13","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1001\/archinte.1985.00360090089015","volume":"145","author":"GP Bodey","year":"1985","unstructured":"Bodey GP, Jadeja L, Elting L (1985) Pseudomonas bacteremia. Retrospective analysis of 410 episodes. Arch Intern Med 145:1621\u20131629","journal-title":"Arch Intern Med"},{"key":"3300_CR14","doi-asserted-by":"publisher","unstructured":"Recio R, Villa J, Viedma E, \u00c1ngeles Orellana M, Lora-Tamayo J, Chaves F (2018) Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: facing the perfect storm. Int J Antimicrob Agents In press \n                    https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.03.018","DOI":"10.1016\/j.ijantimicag.2018.03.018"},{"key":"3300_CR15","unstructured":"ECDC. Antimicrobial resistance surveillance in Europe 2016 (2017) Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). \n                    https:\/\/ecdc.europa.eu\/sites\/portal\/files\/documents\/AMR-surveillance-Europe-2016.pdf\n                    \n                  . Accessed 17 May 2018"},{"key":"3300_CR16","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1093\/cid\/cix346","volume":"65","author":"C Abat","year":"2017","unstructured":"Abat C, Rolain J-M, Dubourg G, Fournier P-E, Chaudet H, Raoult D (2017) Evaluating the clinical burden and mortality attributable to antibiotic resistance: the disparity of empirical data and simple model estimations. Clin Infect Dis 65:S58\u2013S63","journal-title":"Clin Infect Dis"},{"issue":"13","key":"3300_CR17","doi-asserted-by":"publisher","first-page":"e1002184","DOI":"10.1371\/journal.pmed.1002184","volume":"29","author":"MEA Kraker de","year":"2016","unstructured":"de Kraker MEA, Stewardson AJ, Harbarth S (2016) Will 10 million people die a year due to antimicrobial resistance by 2050? PLoS Med 29(13):e1002184","journal-title":"PLoS Med"},{"key":"3300_CR18","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3201\/eid2007.121004","volume":"20","author":"ME Falagas","year":"2014","unstructured":"Falagas ME, Tansarli GS, Karageorgopoulos DE, Vardakas KZ (2014) Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis 20:1170\u20131175","journal-title":"Emerg Infect Dis"},{"key":"3300_CR19","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/nrmicro2319","volume":"8","author":"DI Andersson","year":"2010","unstructured":"Andersson DI, Hughes D (2010) Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol 8:260\u2013271","journal-title":"Nat Rev Microbiol"},{"issue":"108","key":"3300_CR20","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0092-8674(02)00665-7","volume":"8","author":"NA Moran","year":"2002","unstructured":"Moran NA (2002) Microbial minimalism: genome reduction in bacterial pathogens. Cell 8(108):583\u2013586","journal-title":"Cell"},{"key":"3300_CR21","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/infdis\/jiq086","volume":"203","author":"R L\u00f3pez-Rojas","year":"2011","unstructured":"L\u00f3pez-Rojas R, Dom\u00ednguez-Herrera J, McConnell MJ, Docobo-Per\u00e9z F, Smani Y, Fern\u00e1ndez-Reyes M et al (2011) Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii. J Infect Dis 203:545\u2013548","journal-title":"J Infect Dis"},{"key":"3300_CR22","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1128\/AAC.00700-13","volume":"57","author":"S Hraiech","year":"2013","unstructured":"Hraiech S, Roch A, Lepidi H, Atieh T, Audoly G, Rolain J-M et al (2013) Impaired virulence and fitness of a colistin-resistant clinical isolate of Acinetobacter baumannii in a rat model of pneumonia. Antimicrob Agents Chemother 57:5120\u20135121","journal-title":"Antimicrob Agents Chemother"},{"key":"3300_CR23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ijantimicag.2016.06.015","volume":"48","author":"G Levy Hara","year":"2016","unstructured":"Levy Hara G, Kanj SS, Pagani L, Abbo L, Endimiani A, Wertheim HFL et al (2016) Ten key points for the appropriate use of antibiotics in hospitalised patients: a consensus from the Antimicrobial Stewardship and Resistance Working Groups of the International Society of Chemotherapy. Int J Antimicrob Agents 48:239\u2013246","journal-title":"Int J Antimicrob Agents"},{"key":"3300_CR24","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/1469-0691.12791","volume":"20","author":"C Pulcini","year":"2014","unstructured":"Pulcini C, Mainardi J-L (2014) Antimicrobial stewardship: an international emergency. Clin Microbiol Infect 20:947\u2013948","journal-title":"Clin Microbiol Infect"},{"key":"3300_CR25","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1093\/cid\/ciu130","volume":"58","author":"P Brouqui","year":"2014","unstructured":"Brouqui P, Jouve E, Romain F, Sambuc R, Raoult D (2014) Are infectious disease doctors better at caring for infectious diseases than other specialists? Clin Infect Dis 58:1486\u20131487","journal-title":"Clin Infect Dis"},{"key":"3300_CR26","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1093\/cid\/cix433","volume":"65","author":"P Brouqui","year":"2017","unstructured":"Brouqui P, Boudjema S, Soto Aladro A, Chabri\u00e8re E, Florea O, Nguyen H et al (2017) New approaches to prevent healthcare-associated infection. Clin Infect Dis 65:S50\u2013S54","journal-title":"Clin Infect Dis"},{"key":"3300_CR27","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1093\/cid\/cix403","volume":"65","author":"J-C Lagier","year":"2017","unstructured":"Lagier J-C, Aubry C, Delord M, Michelet P, Tissot-Dupont H, Million M et al (2017) From expert protocols to standardized management of infectious diseases. Clin Infect Dis 65:S12\u2013S19","journal-title":"Clin Infect Dis"},{"key":"3300_CR28","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jhin.2015.02.013","volume":"90","author":"JC Lagier","year":"2015","unstructured":"Lagier JC, Million M, Fournier PE, Brouqui P, Raoult D (2015) Faecal microbiota transplantation for stool decolonization of OXA-48 carbapenemase-producing Klebsiella pneumoniae. J Hosp Infect 90:173\u2013174","journal-title":"J Hosp Infect"},{"key":"3300_CR29","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.ijantimicag.2013.08.004","volume":"42","author":"P Brouqui","year":"2013","unstructured":"Brouqui P, Aubry C, Million M, Drancourt M, Raoult D (2013) Totally resistant tuberculosis: will antileprosy drugs be helpful? Int J Antimicrob Agents 42:584\u2013585","journal-title":"Int J Antimicrob Agents"},{"key":"3300_CR30","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ijantimicag.2016.09.029","volume":"49","author":"C Pulcini","year":"2017","unstructured":"Pulcini C, Mohrs S, Beovic B, Gyssens I, Theuretzbacher U, Cars O et al (2017) Forgotten antibiotics: a follow-up inventory study in Europe, the USA, Canada and Australia. Int J Antimicrob Agents 49:98\u2013101","journal-title":"Int J Antimicrob Agents"},{"key":"3300_CR31","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.ijantimicag.2015.09.008","volume":"46","author":"G Dubourg","year":"2015","unstructured":"Dubourg G, Okdah L, Le Page S, Rolain J-M, Raoult D (2015) In vitro activity of \u201cold antibiotics\u201d against highly resistant Gram-negative bacteria. Int J Antimicrob Agents 46:718\u2013720","journal-title":"Int J Antimicrob Agents"},{"key":"3300_CR32","first-page":"1","volume":"XXX","author":"C Abat","year":"2018","unstructured":"Abat C, Raoult D, Rolain J-M (2018) Are we living in an antibiotic resistance nightmare? Clin Microbiol Infect XXX:1\u20132","journal-title":"Clin Microbiol Infect"},{"key":"3300_CR33","doi-asserted-by":"publisher","first-page":"4420","DOI":"10.1128\/AAC.01103-16","volume":"60","author":"P McGann","year":"2016","unstructured":"McGann P, Snesrud E, Maybank R, Corey B, Ong AC, Clifford R et al (2016) Escherichia coli harboring mcr-1 and blaCTX-M on a novel IncF plasmid: first report of mcr-1 in the United States. Antimicrob Agents Chemother 60:4420\u20134421","journal-title":"Antimicrob Agents Chemother"},{"key":"3300_CR34","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG et al (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268\u2013281","journal-title":"Clin Microbiol Infect"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-018-3300-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3300-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3300-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T23:08:18Z","timestamp":1561676898000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-018-3300-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,28]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["3300"],"URL":"https:\/\/doi.org\/10.1007\/s10096-018-3300-0","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,28]]},"assertion":[{"value":"17 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this type of study formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}